Progesteron (Prog)

Engelsk navn:Progesteron
Reagensprodusent:Siemens Medical Solutions Diagnostics
Analyseprinsipp:Progesterone is a solidphase, competitive chemiluminescent enzyme immunoassay.
For detailed description: IMMULITE® 2000; Principles of operation

(Metoden tatt i bruk: 8/3-04)

Referanse:1.Aufrere MB, Benson H. Progesterone: an overview and recent advances. JPharm Sci 1976; 65:783-800.
2.Bauman J. Basal body temperature: unreliable method of ovulation detection. Fertil Steril 1981; 36:729-33.
3.Brown JB. Timing of ovulation. Med J Austral 1977; ii:780-83.
4.Gautray JP, et al. Clinical investigation of the menstrual cycle: clinical, endometrial and endocrine aspects of luteal defect. Fertil Steril 1981; 35:296-303.
5.Hensleigh PA, Fainstat T. Corpus luteum dysfunction: serum progesterone levels in diagnosis and assessment of therapy for recurrent and threatened abortion. Fertil Steril 1979; 32:396-9.
6.Hernandez Horta JL, et al. Direct evidence of luteal insufficiency in women with habitual abortion. Obstet Gynecol 1977; 49:705-8.
7.Jones G. Luteal phase defects. In: Behrman SJ, Kistner RW, editors. Progress in infertility. Boston: Little & Brown, 2nd Edition, 1975: 299-324.
8.Klopper A, Fuchs F. Progestagens. In: Fuchs F, Klopper A, editors. Endocrinology of pregnancy. Hagerstown: Harper & Row, 1977: 99-122.
9.Lehmann F, Bettendorf G. The endocrine shift from a normal cycle to anovulation. In: Insler V, Bettendorf G, editors. Advances in diagnosis and treatment of infertility. Amsterdam: Elsevier/North Holland, 1981: 105-13.
10.March CM. Luteal phase defects. In: Mishell DR, Davajan V, editors. Reproductive endocrinology, infertility and contraception. Philadelphia: F.A. Davis, 1979:469-76.
11.March CM, Goebelsmann U, Nakamura RM and Mishell DR. Roles of estradiol and progesterone in eliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges. J Clin Endocrinol Metab 1979; 49:507-13.
12.Progesterone (Rochester: Bioeducational Publications, 1981). A BIO-ED slide/seminar educational program.
13.Radwanska E, et al. Plasma progesterone and oestradiol estimations in the diagnosis and treatment of luteal insufficiency in menstruating infertile women. Acta Eur Fertil 1976; 7:39-47.
14.Radwanska E, et al. Plasma progesterone levels in normal and abnormal early human pregnancy. Fertil Steril 1978; 30:398-402.
15.Radwanska E, et al. Single midluteal progesterone assay in the management of ovulatory infertility. J Reprod Med 1981; 26:85-89.
16.Sheehan KL, Casper RF, Yen SSC. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control. Science 1982; 215:170-72.
17.Wentz A. Pathophysiology of luteal phase inadequacy. In: Tozzini RI, Reeves G and Pineda RL, editors. Endocrine physiopathology of the ovary. Amsterdam: Elsevier/North Holland, 1980, 257-74.
18.Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry. 2nd ed. Philadelphia: W.B. Saunders, 1994.
19.Hilborn S, Krahn J.Effect of time of exposure to gel-barrier tubes on results for progesterone and some other endocrine tests. Clin Chem 1987; 33:204.
20.Reimers TJ, et al. Effect of storage times and temperature on T3, T4, LH, prolactin, insulin, cortisol, and progesterone concentrations in blood samples from cows. J Anim Sci 1983; 57:683-691.
21.Smith RL. Effect of serum-separating gels on progesterone assays. Clin Chem 1985; 31:1239.
22.National Committee for Clinical Laboratory Standards. Procedures for the collection of diagnostic blood specimens by venipuncture; approved standard. 4th ed. NCCLS Document H3-A4, Wayne, PA: NCCLS, 1998.
23.Vankrieken L. IMMULITE reproductive hormone assays: multicenter reference range data. Los Angeles: Diagnostic Products Corporation, 2000. Document No. ZB157-D.